Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight.
Moonlight AI has raised $3.3M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Moonlight AI's investors include Medin Fund Management Co, QAI Ventures, VP Venture Partners, N&V Capital, Lotus Singapore Group.
Moonlight AI is headquartered in Basel, Switzerland.
Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight.
Moonlight AI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moonlight AI — Funding & Investors." VCBacked, May 6, 2026, https://www.vcbacked.co/company/moonlight-ai. Accessed October 29, 2026.
VCBacked. (2026). Moonlight AI — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/moonlight-ai
{{cite web |title=Moonlight AI — Funding & Investors |url=https://www.vcbacked.co/company/moonlight-ai |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated